Rothschild & Co Asset Management US’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
BFA
TIM
VFA
FIM
DIA
BA
Rothschild & Co Asset Management US's PAHC Position: Q2 2016 in Review
Rothschild & Co Asset Management US sold out of Phibro Animal Health (PAHC) in Q2 2016, closing a stake of 309,967 shares — an estimated $8.38M sold.
Rothschild & Co Asset Management US first reported a position in PAHC in Q1 2015 and held it in 5 quarters. The position peaked at $10.4M in Q2 2015. 123 funds tracked by Wall St. Rank hold PAHC as of Q2 2016.
- Rothschild & Co Asset Management US reported no remaining Phibro Animal Health position as of Q2 2016 after selling out during the quarter.
- Rothschild & Co Asset Management US sold 309,967 Phibro Animal Health shares in Q2 2016, an estimated $8.38M.
- Rothschild & Co Asset Management US first reported a position in Phibro Animal Health in Q1 2015 and held it in 5 quarters.
- Rothschild & Co Asset Management US's Phibro Animal Health position peaked at $10.4M in Q2 2015.
- 123 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2016.
Based on Rothschild & Co Asset Management US's 13F filing for Q2 2016, filed 3 Aug 2016.